What makes Etanercept biosimilar a trusted choice in clinical practice?


	Chairperson/s: Prof. Hoon-Suk Cha and Prof. Kunihiro Yamaoka
13:40-13:50	Welcome Remarks: Introduction
13:50-14:10	Etanercept: A pillar of RA Therapy with Proven Safety and Long-term Data Prof. Yeon-Ah Lee
14:10-14:30	Biosimilars for rheumatoid arthritis: clinical evidence, market realities, and the road ahead Prof. Masayoshi Harigai
14:30-15:00	History of Eucept(Etanercept) – Beyond the Similar Jungeun Park
15:00-15:10	Closing Remarks: Q&A and Discussion All

13:40-13:50

Welcome Remarks: Introduction

13:50-14:10

Etanercept: A pillar of RA Therapy with Proven Safety and Long-term Data
Prof. Yeon-Ah Lee

14:10-14:30

Biosimilars for rheumatoid arthritis: clinical evidence, market realities, and the road ahead
Prof. Masayoshi Harigai

14:30-15:00

History of Eucept(Etanercept) – Beyond the Similar
Jungeun Park

15:00-15:10

Closing Remarks: Q&A and Discussion
All

Share